Efgartigimod Alfa + Monoclonal Antibodies Interaction

Moderateinteraction on record

Description

Concomitant use may lower systemic exposures and reduce effectiveness of monoclonal antibodies. Closely monitor for reduced effectiveness.

Mechanism

VYVGART binds to human neonatal Fc receptor (FcRn), which may lower systemic exposures of FcRn-binding medications

Source: NLP:efgartigimod alfa

Related drug profiles

All Efgartigimod Alfa interactions →All Monoclonal Antibodies interactions →
Share this page:XFacebookWhatsAppReddit